Vitafort
Vitafort is a Brazilian veterinary pharmaceutical laboratory, founded in 1980 and headquartered in Ribeirão Preto, that uses proprietary hydrolysis technology to extract amino acids and polypeptides from animal glands and organs, selling 10 veterinary products — primarily mastitis prevention treatments for dairy cattle — to SMB producers across Brazil via direct sales and contract manufacturing.
- Company typePrivate
- Founded1980
- HeadquartersRibeirão, Brazil
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vitafort does
Vitafort is a privately held Brazilian veterinary pharmaceutical laboratory headquartered in Ribeirão Preto, São Paulo, that has operated continuously since 1980. The company develops and manufactures a portfolio of 10 veterinary products for animal health applications, centered on a proprietary hydrolysis technology for extracting amino acids and polypeptides from animal glands and organs. This biochemistry is applied to stimulate anabolic metabolism in livestock and to control mastitis in dairy cattle, the company's primary commercial focus. The core product line includes Mastiplus BR and Mastiplus Beta Pó (mastitis prevention and somatic cell count reduction), the Florafort range of topical pastes and powders spanning bovine, equine, and companion-animal applications, Silofort for silage management, Pró-Kashi as a nutritional supplement, and Pro Acqua and Pro Fish Acqua Biorremediador for aquaculture water quality and bioremediation.
The company's commercial model is sales-led and domestically focused, distributing across Brazil through toll-free televendas, WhatsApp direct contact, and website-driven inquiries. Pricing is quote-based with no public price list, and the company also operates a white-label and contract manufacturing service that allows partners to sell Vitafort-formulated products under their own brand. The primary customer segment is SMB dairy cattle producers seeking mastitis prevention and milk quality improvement, with secondary segments in equine health and aquaculture. Vitafort is organized as Laboratorio Vitafort Industria e Comercio de Produtos Veterinarios LTDA, a limited liability company under Brazilian law (CNPJ 44.236.073/0001-52), with no disclosed parent company, institutional investors, or external funding.
Operationally, Vitafort employs 11-50 people and operates from a single manufacturing and headquarters facility in Ribeirão Preto. The company holds no disclosed patents, certifications, or regulatory approvals in the source data, and relies on its 45-year brand presence in the Brazilian dairy sector as its principal commercial differentiator. There is no evidence of AI, machine learning, software platform, API, or digital integration capability; the company's competitive position is grounded in its biochemical formulation expertise and its established direct-sales network with Brazilian livestock producers.
Vitafort firmographics
Firmographics- Name
- Vitafort
- Legal name
- Laboratorio Vitafort Industria e Comercio de Produtos Veterinarios LTDA
- Website
- https://vitafort.com.br
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vitafort is a Brazilian veterinary pharmaceutical laboratory, founded in 1980 and headquartered in Ribeirão Preto, that uses proprietary hydrolysis technology to extract amino acids and polypeptides from animal glands and organs, selling 10 veterinary products — primarily mastitis prevention treatments for dairy cattle — to SMB producers across Brazil via direct sales and contract manufacturing.
- Ownership category
- akta.pro rank
Vitafort industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Veterinary Services (54194), Other Animal Food Manufacturing (311119)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
- akta.pro secondary industries
- Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)
Keywords
Where Vitafort is headquartered
LocationHeadquarters
- HQ city
- Ribeirão
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Vitafort business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Product Sales: Sale of veterinary pharmaceutical products for animal health including mastitis prevention, metabolism stimulation, and bioremediation solutions. Products include Mastiplus BR, Florafort, Silofort, Pró-Kashi, Pro Acqua, and biorremediador products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for veterinary products |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Vitafort product offering
Product offeringCore offering
Vitafort manufactures and sells veterinary pharmaceutical products for livestock, with a core focus on mastitis prevention and somatic cell count (C.C.S.) reduction in dairy cattle. The company holds proprietary technology for extracting amino acids and polypeptides from animal gland and organ hydrolysis, used in products such as Mastiplus BR and the Florafort line (bovine, equine, pet). The portfolio also includes nutritional supplements (Pró-Kashi), silage management products (Silofort), and aquaculture bioremediation products (Pro Acqua, Pro Fish). The company operates from Ribeirão Preto, São Paulo, Brazil and has served as a reference in mastitis prevention since 1980.
Product overview
Vitafort is a Brazilian animal health company specializing in veterinary pharmaceutical products for livestock, with a portfolio of 10 named products spanning mastitis prevention, topical treatments, nutritional supplements, and aquaculture solutions. The product line centers on its proprietary amino acid and polypeptide extraction technology derived from animal gland and organ hydrolysis, marketed under brands including Mastiplus (for mastitis control in dairy cattle), Florafort (topical pastes and powders for bovine, equine, and pet applications), Pró-Kashi (nutritional supplement), Silofort (silage management), and Pro Acqua/Pro Fish (aquaculture water treatment). The company has operated since 1980 and positions itself as a contract manufacturer offering white-label production services alongside its branded products.
Differentiator
Problem solved
Functional benefit
Brands
- Mastiplus BR: Product for mastitis prevention in cattle
- Mastiplus Beta Pó
- Florafort Pasta Bovina
- Florafort Pasta Equina
- Silofort
- Pró-Kashi
- Pro Acqua
- Pro Fish Acqua Biorremediador
- Florafort Pet
- Florafort Pó
Products and services
- Mastiplus BR
Quantifiable outcome
- Reference in mastitis prevention and reduction of C.C.S.
Companies that use Vitafort
Customer profileSegments3 records
Ideal customer profiles4 records
Vitafort technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Vitafort partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Vitafort competitors and assessment
Company assessmentBroad incumbents
- Elanco Animal Health: Global animal health company with a cattle-dairy franchise including mastitis and metabolic health products. Comparable as a broad incumbent with significant commercial reach in the Brazilian dairy segment Vitafort serves.
- Ceva Santé Animale: Global animal health company with a strong livestock pharmaceuticals and biologics portfolio. Comparable as a multi-species veterinary pharma competitor with mastitis, vaccine, and reproductive health products serving dairy producers worldwide.
- Virbac: Global veterinary pharmaceutical company with significant livestock and companion animal product lines. Comparable as a multi-species animal health pharma competitor with mastitis, reproduction, and nutrition offerings in Latin America.
- Vetoquinol: French veterinary pharmaceutical group with livestock and companion animal therapeutics, including mastitis products. Comparable as an established veterinary pharma peer with similar therapeutic categories and global Latin American distribution.
- Zoetis: World's largest animal health company, with leading mastitis and dairy-cattle therapeutic franchises. Comparable as the dominant incumbent in veterinary pharmaceuticals and biologics that Vitafort competes against at the high end of the Brazilian market.
- Boehringer Ingelheim Animal Health: Major global animal health division with vaccines and therapeutics across livestock species. Comparable as a broad incumbent whose biologics and cattle health portfolio overlap with Vitafort's mastitis and metabolic therapy positioning.
Regional players
- Biovet: Brazilian veterinary biologics and pharmaceutical manufacturer focused on livestock health. Comparable as a domestic peer in veterinary product manufacturing for Brazilian dairy and beef cattle producers.
- Vallée: Brazilian veterinary pharmaceutical laboratory with a long history in livestock health products. Comparable as a heritage Brazilian animal health lab competing in similar mastitis, reproduction, and nutritional therapeutic categories.
Direct peers
- Ourofino Saúde Animal: Brazilian veterinary pharmaceuticals and animal health company with a broad portfolio across livestock and companion animals. Most direct domestic comparable: a Brazilian manufacturer of veterinary medicines selling to producers and pet owners via similar channels.
- Hipra: Spanish veterinary pharmaceutical and vaccine company with strong livestock focus. Comparable as a privately held animal health specialist competing in cattle therapeutics and biologics in Latin American markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Vitafort social profiles
Digital presenceVitafort financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitafort leadership team
Management profileNumber of profiles
Vitafort funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitafort M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitafort
What does Vitafort do?
Vitafort manufactures and sells veterinary pharmaceutical products for livestock, with a core focus on mastitis prevention and somatic cell count (C.C.S.) reduction in dairy cattle. The company holds proprietary technology for extracting amino acids and polypeptides from animal gland and organ hydrolysis, used in products such as Mastiplus BR and the Florafort line (bovine, equine, pet). The portfolio also includes nutritional supplements (Pró-Kashi), silage management products (Silofort), and aquaculture bioremediation products (Pro Acqua, Pro Fish). The company operates from Ribeirão Preto, São Paulo, Brazil and has served as a reference in mastitis prevention since 1980.
Is Vitafort a public or private company?
Vitafort is a private company. It is classified as unknown and is currently operating.
When was Vitafort founded?
Vitafort was founded in 1980. It employs 11 to 50 people.
Where is Vitafort based?
Vitafort is headquartered in Ribeirão, Brazil, in the Latin America region.
How does Vitafort make money?
One revenue line is on record: veterinary Product Sales.
Who are Vitafort's main competitors?
Broad incumbents on record are Elanco Animal Health, Ceva Santé Animale, Virbac, Vetoquinol, Zoetis and Boehringer Ingelheim Animal Health. Regional players are Biovet and Vallée. Direct peers are Ourofino Saúde Animal and Hipra.
Does Vitafort have an API?
No public API is recorded for Vitafort.
What industry is Vitafort in?
Vitafort's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of AFAEANAK, Veterinary Pharmacy, Vaccine & Biologics Services. Its NAICS code is 54194 and its SIC code is 2836.